CClinicalTrials.gg
Status unknownNCT05378438Updated Jul 6, 2022

Impact of Microbe Literacy Initiative on Improved Vaccine Uptake in Peri-urban Slum Areas in Kathmandu, Nepal

An interventional study of Microbe literacy Program in the form of workshop in Vaccine Acceptance, sponsored by Nepal Health Research Council. Status unknown at 1 site in Nepal. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-06.

Sponsored by Nepal Health Research Council · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Jul 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
1,252
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study is designed to assess the impact of the first introduction of microscope-based health education on people's attitude and practice towards disease prevention in Nepal, measured by vaccine acceptance rate. Such health education has an important role to play in communities where vaccine acceptance is low.

02

Conditions studied

  • Vaccine Acceptance
03

In context

Lead sponsor

Nepal Health Research Council is the lead sponsor of 8 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • People aged 18 years or older who are resident of the study target area
  • People who stayed at least for 6 months on the area of study
  • People who agrees with the procedure of study and follow ups visits
  • People who provide consent for their participation will be recruited in the study.

Exclusion criteria

Exclusion Criteria:

  • People under 18 years of age will not be enrolled into study due to their limitation of understanding and implementation of the content of workshop given as intervention.
  • People who do not wish to participate in the trial
  • Those with currently ongoing court hearing and deprive of freedom will not be enrolled for the study.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,252 participants (estimated)

Study arms

  • Experimental
    Intervention Arm

    Participants allocated in this arm will be approached for a workshop related to microbe literacy. Using a microscope, live demonstration of the biological samples brought by the participants will be carried out by the team of researchers. Participants will be assisted to place biological materials under the microscope, manipulate the slides and discover the profusion of microbial life from the immediate environment. The session will be followed by question and answer round related to concurrent hygiene practices and basic sanitation to prevent infections including vaccines.

    Other: Microbe literacy Program in the form of workshop

  • No intervention
    Control arm

    Participants in this arm will be consented for the study and baseline data collection will be made but there will not be any intervention. Data will be collected for baseline as well as post interventional vaccination status among the studied population.

Interventions

  • OtherMicrobe literacy Program in the form of workshop

    Two to Three hours of workshop on microbe literacy will be conducted as an intervention. Workshop includes discussion on various common microorganisms causing diseases, their sources, relationship with surroundings and management. Prime focus of the session will be on management via treatments and risk reduction via vaccination.

06

What researchers measure

Primary outcomes

  1. Differential vaccine acceptance rates between intervention and control group

    Data will be collected for baseline as well as post intervention after 3 months of workshop. For both the intervention and control group, number of vaccinated among the participants for provided COVID-19 vaccine and Typhoid vaccine will be made. Comparative analysis will be made in both the study groups before and after the intervention program.

    Time frame: Within 3 months of intervention

07

Study locations

1 site
  • Nepal Health Research Council
    Kathmandu, Bagmati 44600, Nepal
    • Dr. Pradip Gyanwali, MD · Contact
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 6, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05378438
Lead sponsor
Nepal Health Research Council
Collaborators
Microbe Literacy Initiative, Partnership for Sustainable Development Nepal (PSDNepal)
Responsible party
Dr. Pradip Gyanwali,MD (Executive Chief, Nepal Health Research Council) — Principal investigator
First posted
May 18, 2022
Start date
Jul 15, 2022 (estimated)
Primary completion
Sep 30, 2022 (estimated)
Completion
Apr 17, 2023 (estimated)
Last update
Jul 6, 2022

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion